Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Nevro Names Kevin Thornal As Its New CEO; Investors Remain Disappointed In Results

Apr 21 2023

• By Reed Miller

low back pain — • Source: Alamy

Related Content

Nevro Attacks Pain And Competition With Individualized AI-Enabled Spinal Cord Stimulator

Apr 06 2023

Nevro’s HFX Offers Durable Benefit In People Suffering Diabetic Pain

Jun 07 2022

Saluda’s Evoke SCS Set To Join Competitive US Spine-Stim Market In Late 2022

Mar 09 2022

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

Jan 06 2021

Minute Insight: Abbott Receives US FDA Clearance For Spinal Cord Stimulator

Dec 19 2022

Related Companies

Nevro Corp.

Hologic, Inc.

Stryker Corporation

Abbott

Additional Topics

Executive Changes Sales & Earnings Business Strategies Commercial Companies Leadership Research & Development Neurology Medical Device

More from Leadership

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window